We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Key Molecule for Flu Infection, a Novel Target for Drug Development?

News   May 31, 2018 | Original story from Hokkaido University

 
Key Molecule for Flu Infection, a Novel Target for Drug Development?

Human bronchial epithelial cells cultured with (right) or without (left) a calcium channel blocker (CCB) prior to exposure to IAV. Red signals show infected and replicated IAV. Treatment with CCB significantly suppressed IAV infections. Credit: Fujioka Y. et al., Cell Host & Microbe, May 17, 2018

 
 
 

RELATED ARTICLES

Protein Switches Sides in Leukemia

News

Researchers have discovered that an epigenetic protein called EZH2 delays the development of acute myeloid leukemia (AML) but then switches sides once the disease is established to help maintain tumor growth.

READ MORE

Device Would Allow TB Dosing to Switch From Daily to Monthly

News

A drug delivery device is under development, which works by slowly releasing antibiotics directly into the patient's stomach. This would allow patients to switch from daily to monthly doses, reducing the burden of tuberculosis treatment.

READ MORE

From Mirror-image Biology to Enhanced Therapeutic Proteins

News

Biomolecules are being synthesized in their mirror-image form, as part of a bigger long-term goal: to create simple, artificial biological systems in mirror-image form that correspond to those in nature but do not interact with the environment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE